Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hengming Ke

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|May 9, 2006
Essential role of the B23/NPM core domain in regulating ARF binding and B23 stabilityTakeharu Enomoto, Mikael S Lindström, Aiwen Jin, et al.
Handbook of Experimental Pharmacology|September 23, 2010
Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compoundsSharron H Francis, Konjeti R Sekhar, Hengming Ke, et al.
Molecular Pharmacology|October 26, 2007
Conformational variations of both phosphodiesterase-5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafilHuanchen Wang, Mengchun Ye, Howard Robinson, et al.
The Journal of Biological Chemistry|December 12, 2003
Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivityQing Huai, Yudong Liu, Sharron H Francis, et al.
Molecular Microbiology|October 20, 2007
Crystal structure of the Leishmania major phosphodiesterase LmjPDEB1 and insight into the design of the parasite-selective inhibitorsHuanchen Wang, Zier Yan, Jie Geng, et al.
Journal of Medicinal Chemistry|February 4, 2010
Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesisHuanchen Wang, Xuan Luo, Mengchun Ye, et al.
Handbook of Experimental Pharmacology|June 23, 2011
Therapeutic potential of phosphodiesterase inhibitors in parasitic diseasesYasmin Shakur, Harry P de Koning, Hengming Ke, et al.
Biochemistry|November 6, 2008
Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivityHuanchen Wang, Zier Yan, Serena Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2007
Structural insight into substrate specificity of phosphodiesterase 10Huanchen Wang, Yudong Liu, Jing Hou, et al.
Biochemical Pharmacology|March 19, 2008
An insight into the pharmacophores of phosphodiesterase-5 inhibitors from synthetic and crystal structural studiesGong Chen, Huanchen Wang, Howard Robinson, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|May 9, 2006
Essential role of the B23/NPM core domain in regulating ARF binding and B23 stabilityTakeharu Enomoto, Mikael S Lindström, Aiwen Jin, et al.
Handbook of Experimental Pharmacology|September 23, 2010
Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compoundsSharron H Francis, Konjeti R Sekhar, Hengming Ke, et al.
Molecular Pharmacology|October 26, 2007
Conformational variations of both phosphodiesterase-5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafilHuanchen Wang, Mengchun Ye, Howard Robinson, et al.
The Journal of Biological Chemistry|December 12, 2003
Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivityQing Huai, Yudong Liu, Sharron H Francis, et al.
Molecular Microbiology|October 20, 2007
Crystal structure of the Leishmania major phosphodiesterase LmjPDEB1 and insight into the design of the parasite-selective inhibitorsHuanchen Wang, Zier Yan, Jie Geng, et al.
Journal of Medicinal Chemistry|February 4, 2010
Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesisHuanchen Wang, Xuan Luo, Mengchun Ye, et al.
Handbook of Experimental Pharmacology|June 23, 2011
Therapeutic potential of phosphodiesterase inhibitors in parasitic diseasesYasmin Shakur, Harry P de Koning, Hengming Ke, et al.
Biochemistry|November 6, 2008
Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivityHuanchen Wang, Zier Yan, Serena Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2007
Structural insight into substrate specificity of phosphodiesterase 10Huanchen Wang, Yudong Liu, Jing Hou, et al.
Biochemical Pharmacology|March 19, 2008
An insight into the pharmacophores of phosphodiesterase-5 inhibitors from synthetic and crystal structural studiesGong Chen, Huanchen Wang, Howard Robinson, et al.
Pageof 7